Search & Filter

GM's June 2017 issue is out now, and all the articles from the print journal are also published online. Find out what's in this month's issue here.

The anti-epileptic drug (AED) lacosamide (VIMPAT) has received a positive opinion on a licence extension, meaning it can be used as monotherapy and adjunctive therapy in the treatment of focal-onset seizures (FOS) in children from 4-16 years of age.

Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD), as this will help them to manage the increased risk of cardiovascular disease (CVD), NICE has said.

The government's plan to tackle air pollution has been hailed as a €œbig step forward€ by the British Heart Foundation, although they warned it's unlikely many of the people living in today's polluted streets will see many of the benefits.

NICE has published a Technology Appraisal Guidance (TAG) recommending roflumilast for use within NHS England as an add-on option to treat adults with severe COPD who continue to experience exacerbations despite triple inhaled therapy.

Nutrition advice aimed at children also improves parents' diets, according to research published in the European Journal of Preventive Cardiology.

Patients across England face waiting longer than a week for a GP or practice nurse appointment on more than 100 million occasions by 2022,  the Royal College of General Practitioners has warned.

Exhibiting at the GM Conference gives you the chance to meet professionals in primary and secondary care with an interest in 50+ healthcare. Find out more.

Information about speaker sessions at the GM Conference 2019, The Ageing Patient: Midlife and Beyond. 

Age UK has urged for a debate into how we fund health and care after it was announced that England's average life expectancy rates are slowing dramatically.

Survival for UK cancer patients is lower than in much of Europe, according to a new report.  

The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of LIXIANA (edoxaban) in patients with atrial fibrillation (AF) undergoing cardioversion, pharmaceutical Daiichi Sankyo has announced.

Medical device manufacturer medi has launched a new knee support, which works as an add on to the treatment of patella tip syndrome.

The Scottish Medicines Consortium has published advice accepting three new medicines for routine use by NHS Scotland.

Professor Passmore presents a piece on Cognitive impairment and Alzheimer's disease: a glimpse of the future from The GM Conference 2016